Other

OCI Reclassification Adjustment for Sale of Securities

Humana OCI Reclassification Adjustment for Sale of Securities decreased by 97.0% to $1.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $1.00M to $1.00M.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2015
Last reportedQ1 2026Apr 29, 2026
Metric ID: anet_oci_reclassification_adjustment_sale_of_securities

Historical Data

12 periods
 Q3 '21Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$12.00M-$39.00M-$46.00M$7.00M-$3.00M$1.00M-$1.00M$8.00M$1.00M$5.00M$33.00M$1.00M
QoQ Change-425.0%-17.9%+115.2%-142.9%+133.3%-200.0%+900.0%-87.5%+400.0%+560.0%-97.0%
YoY Change-425.0%+92.3%+102.2%-114.3%+366.7%+0.0%+600.0%+312.5%+0.0%
Range-$46.00M$33.00M
CAGR-59.5%
Avg YoY Growth+103.8%
Median YoY Growth+92.3%

Frequently Asked Questions

What is Humana's oci reclassification adjustment for sale of securities?
Humana (HUM) reported oci reclassification adjustment for sale of securities of $1.00M in Q1 2026.
How has Humana's oci reclassification adjustment for sale of securities changed year-over-year?
Humana's oci reclassification adjustment for sale of securities decreased by 0.0% year-over-year, from $1.00M to $1.00M.